ESMO Consensus Guidelines: Early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up

Published in 2014 - Ann Oncol (2014) doi: 10.1093/annonc/mdu089
Authors: J. Vansteenkiste, L. Crino, C. Dooms, J.Y. Douillard, C. Faivre-Finn, E. Lim, G. Rocco, S. Senan, P. Van Schil, G. Veronesi, R. Stahel, S. Peters, E. Felip

Written to complement the ESMO Clinical Practice Guidelines, this manuscript focuses on stage I and II disease. The publication discusses LDCT Screening in non-clinical trial patients, whether or not tissue based diagnosis is necessary before surgery or radiation, functional cardiopulmonary evaluation before resection, when sub-lobular resection is an acceptable therapeutic choice, optimal management of multifocal lung cancer, and beyond staging: which factors to consider when selecting adjuvant treatment.

  • optimal follow-up after surgery and SABR

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings